Mediastinal (thymic) large B-cell lymphoma, nodes mult site is a rare and aggressive form of non-Hodgkin lymphoma that primarily affects the thymus gland and surrounding lymph nodes. This condition is characterized by the proliferation of large B-cells, leading to significant clinical manifestations such as mediastinal masses and systemic symptoms. Accurate coding with ICD-10 Code C85.28 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C85.28 specifically identifies Mediastinal (thymic) large B-cell lymphoma affecting multiple lymph nodes. This code is utilized when documenting cases of this aggressive lymphoma type, which can lead to significant morbidity. It is crucial for healthcare providers to use this code accurately in clinical documentation and billing to reflect the patient's condition and ensure appropriate reimbursement.
Mediastinal (thymic) large B-cell lymphoma is a subtype of non-Hodgkin lymphoma that arises from B-lymphocytes in the thymus gland, often presenting with large mediastinal masses. The etiology is not fully understood, but it is associated with genetic mutations and immune dysregulation. Prompt medical attention is necessary due to its aggressive nature and potential for rapid progression.
ICD-10 Code C85.28 plays a vital role in SOAP notes by documenting the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring that the patient's condition is accurately represented for clinical decision-making and billing purposes.
In SOAP notes, ICD-10 Code C85.28 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Mediastinal (thymic) large B-cell lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Mediastinal (thymic) large B-cell lymphoma requires urgent medical intervention, often necessitating hospitalization for intensive treatment. Standard treatment approaches include chemotherapy and, in some cases, radiation therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C85.28 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count with automated differential. |
| 77014 | Radiologic examination, lymphatic system. |
| 99223 | Initial hospital care, typically 70 minutes. |
Common Questions About Using ICD-10 Code C85.28 for Mediastinal (thymic) large B-cell lymphoma, nodes mult site
What are the common symptoms of Mediastinal (thymic) large B-cell lymphoma?
Common symptoms include persistent cough, shortness of breath, unexplained weight loss, fever, night sweats, and fatigue. These symptoms arise due to the presence of a large mediastinal mass and systemic involvement.
How is Mediastinal (thymic) large B-cell lymphoma diagnosed?
Diagnosis typically involves imaging studies such as chest X-rays or CT scans, along with biopsy of the mediastinal mass to confirm the presence of large B-cells. Laboratory tests may also be performed to assess overall health.
What treatment options are available for this condition?
Treatment usually involves chemotherapy, and in some cases, radiation therapy may be indicated. Supportive care is also essential to manage symptoms and improve quality of life.
Is Mediastinal (thymic) large B-cell lymphoma contagious?
No, Mediastinal (thymic) large B-cell lymphoma is not contagious. It is a type of cancer that arises from the body's own cells and cannot be transmitted from one person to another.
Clinical Notes
SOAP notes
DAP notes
AI medical notes